-+ 0.00%
-+ 0.00%
-+ 0.00%

ELEDON PHARMACEUTICALS ANNOUNCES ISLET CELL TRANSPLANTATION IND SUBMISSION, FIRST PATIENTS ENROLLED IN MULTIPLE TRANSPLANT PROGRAMS, AND REAFFIRMS PLAN TO INITIATE PHASE 3 KIDNEY TRANSPLANTATION TRIAL IN FOURTH QUARTER 2026

Reuters·09/03/2026 11:00:01

Please log in to view news